These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 21052020

  • 21. A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy.
    Sharma UC, Sonkawade SD, Spernyak JA, Sexton S, Nguyen J, Dahal S, Attwood KM, Singh AK, van Berlo JH, Pokharel S.
    Circ Heart Fail; 2018 Aug; 11(8):e004867. PubMed ID: 30354563
    [Abstract] [Full Text] [Related]

  • 22. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M, Taniguchi H, Koya D, Kanasaki K, Sho R, Kato Y, Kojima R, Haneda M, Inomata N.
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [Abstract] [Full Text] [Related]

  • 23. Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus.
    Nakagawa P, Masjoan-Juncos JX, Basha H, Janic B, Worou ME, Liao TD, Romero CA, Peterson EL, Carretero OA.
    Physiol Rep; 2017 Jan; 5(2):. PubMed ID: 28126732
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension.
    Gao Y, Yu W, Song J, Nie J, Cui Z, Wen S, Liu B, Liang H.
    Hypertens Res; 2023 Aug; 46(8):1934-1948. PubMed ID: 37248323
    [Abstract] [Full Text] [Related]

  • 27. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
    Wu C, Chen Z, Zhang L, Zhu Y, Deng M, Huang C, Liu Y, Zhu Q, Wang L.
    Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
    [Abstract] [Full Text] [Related]

  • 28. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.
    Gross V, Lippoldt A, Bohlender J, Bader M, Hansson A, Luft FC.
    J Am Soc Nephrol; 1998 Mar; 9(3):346-54. PubMed ID: 9513896
    [Abstract] [Full Text] [Related]

  • 29. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.
    Weng HC, Lu XY, Xu YP, Wang YH, Wang D, Feng YL, Chi Z, Yan XQ, Lu CS, Wang HW.
    Mol Med; 2021 Nov 13; 27(1):147. PubMed ID: 34773993
    [Abstract] [Full Text] [Related]

  • 30. Renal Damages in Deoxycorticosterone Acetate-Salt Hypertensive Rats: Assessment with Diffusion Tensor Imaging and T2-mapping.
    Ko SF, Yip HK, Zhen YY, Hung CC, Lee CC, Huang CC, Ng SH, Chen YL, Lin JW.
    Mol Imaging Biol; 2020 Feb 13; 22(1):94-104. PubMed ID: 31065896
    [Abstract] [Full Text] [Related]

  • 31. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L, Duce B, Miric G, Sernia C.
    J Am Soc Nephrol; 1999 Jan 13; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
    Pu Q, Amiri F, Gannon P, Schiffrin EL.
    J Hypertens; 2005 Feb 13; 23(2):401-9. PubMed ID: 15662229
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. CXCL16 Deficiency Attenuates Renal Injury and Fibrosis in Salt-Sensitive Hypertension.
    Liang H, Ma Z, Peng H, He L, Hu Z, Wang Y.
    Sci Rep; 2016 Jun 29; 6():28715. PubMed ID: 27353044
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.